StockData
Invivyd, Inc. logo

Invivyd, Inc. (IVVD) stock

IVVDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3048% below fair value
$0.51−0.03 (-4.67%)

Close on Nov 17, 2026Market cap $151.09MP/E –Yield –

Invivyd profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Invivyd's profit margin for the twelve months ending Jun 30, 2026 was -183.9%. For fiscal 2025 it was -98.2%, against -669.4% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-98.2%+571.2
FY2024Dec 31, 2024-669.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-310.8%−186.4
Q1 FY2026Mar 31, 2026-301.2%−157.1
Q4 FY2025Dec 31, 2025-64.3%+69.1
Q3 FY2025Sep 30, 2025-79.7%+573.4
Q2 FY2025Jun 30, 2025-124.4%+1962.5
Q1 FY2025Mar 31, 2025-144.1%–
Q4 FY2024Dec 31, 2024-133.5%–
Q3 FY2024Sep 30, 2024-653.1%–
Q2 FY2024Jun 30, 2024-2086.9%–

More Invivyd figures

See a number that looks wrong?